Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1782 of 6351
-
New hope for rare cancer: oral pill targets early mesothelioma in High-Risk patients
Disease control Recruiting nowThis is a Phase II study to determine the rate of stabilization or disease improvement from investigational decitabine/cedazuridine (INQOVI) treatment in subjects with BRCA1-Associated Protein-1 (BAP1) Cancer Predisposition Syndrome (CPDS) and subclinical, early-stage mesotheliom…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Second chance: new drug offers hope for thyroid eye disease Non-Responders
Disease control CompletedThe investigational drug, VRDN-001, is a monoclonal antibody that inhibits the activity of a cell surface receptor called insulin-like growth factor-1 receptor (IGF-1R). Inhibition of IGF-1R may help to reduce the inflammation and associated tissue swelling that occurs in partici…
Phase 3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New depression drug GM-2505 enters Mid-Stage trial
Symptom relief Recruiting nowThis is a three-part Phase 2a study. The aim of Part A is to assess the safety and tolerability and preliminary antidepressant efficacy in patients with MDD who are not currently on an antidepressant therapy. The aim of Part B is to assess the antidepressant efficacy, safety and …
Phase 2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Brain surgery showdown: which chiari fix works best?
Disease control CompletedThe purpose of this study is to determine whether a posterior fossa decompression and duraplasty with or without tonsil manipulation results in better patient outcomes with fewer complications and improved quality of life in those who have Chiari malformation type I and syringomy…
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Engineered immune cells take on advanced cancers in early trial
Disease control OngoingTo learn if KSQ-001EX is safe to give to participants with advanced forms of solid tumors.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug AMT-253 enters human trials for Tough-to-Treat cancers
Disease control Recruiting nowThis is a non-randomized, open-label, multicenter Phase I/II study of AMT-253 in patients with Unresectable or Metastatic Malignant Melanoma and other Advanced Solid Tumors. This study include phase I dose escalation and phase II dose expansion.
Phase 1/2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:59 UTC
-
Antidepressant shows promise for arthritis relief in new trial
Disease control CompletedRheumatoid arthritis (RA) is a systemic chronic auto-inflammatory disorder which imposes a remarkable burden of morbidity and mortality on global health. The complex interaction between genetics, environment, and immunological response contribute to RA pathogenesis. Current treat…
Phase 3 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
IPad test could revolutionize dementia detection in underserved communities
Diagnosis OngoingOur study intends to offer 'real world' evidence of a viable, sustainable means to mobilize primary care via a comprehensive strategy for detecting cognitive impairment and dementias, advancing next steps for referral, and participating in the care planning and management of affe…
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Weekly MRI boosts radiation precision for brain cancer patients
Disease control OngoingThe purpose of this study is to find out if performing additional Magnetic Resonance Image (MRI) scans of the subjects' brain during each week of the radiation treatment of their high-grade glioma will help improve the radiation treatment.
Sponsor: Columbia University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Which nerve block eases chest surgery pain better?
Symptom relief CompletedThe aim of the study is to compare the analgesic efficacy and safety of midpoint transverse process to pleura to pleural block versus Paravertebral block for post thoracic surgery analgesia. Primary outcome: Postoperative morphine consumption in the first 24 hours after surgery…
Sponsor: Tanta University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New antibody drug takes aim at Hard-to-Treat brain cancers
Disease control Recruiting nowThis study (1438-0003) is open to adults with a tumour in the brain that is positive for the tumour marker delta-like 3 (DLL3). This study is in people with advanced cancer for whom previous treatment was not successful. The purpose of this study is to find out the highest dose …
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for HS sufferers: Long-Term drug safety trial underway
Disease control OngoingThe purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 \[NCT05620823\] or I…
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New combo therapy aims to tame rare liver disease in Long-Term trial
Disease control Recruiting nowAn Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Combination with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis (PBC)
Phase 3 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug combo offers hope for Hard-to-Treat myeloma
Disease control Recruiting nowPhase 1 is to find the recommended dose of belumosudil mesylate that can be given to patients with relapsed/refractory MM. Phase 2 is to learn if the dose of belumosudil mesylate found in Phase 1 can help to control the disease.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for rare appendix cancer: targeted chemotherapy delivered straight to the belly
Disease control Recruiting nowTo find the recommended dose of the drug paclitaxel that can be given intraperitoneally (given directly into the abdominal cavity) to participants with metastatic appendiceal adenocarcinoma.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a common diabetes drug ease knee arthritis pain?
Symptom relief Recruiting nowKnee osteoarthritis (OA) is a chronic, painful disease associated with considerable morbidity, costs and disability. It is estimated that over a third of people aged over 60 have radiographic knee OA2 and over 50% of these with knee OA will go on to have a total knee replacement …
Phase 3 • Sponsor: Mostafa Bahaa • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can magnetic pulses ease nerve pain and fibromyalgia?
Symptom relief Recruiting nowThis study will investigate the efficacy and safety of "deep" rTMS on neuropathic pain or fibromyalgia. It will be randomized and sham controlled and will last 3 months. Patients will be randomized to receive acctive rTMS or sham rTMS and will receive repeated rTMS sessions (5 da…
Sponsor: Nadine ATTAL • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to outsmart recurrent ovarian cancer
Disease control Recruiting nowThis is a clinical trial using CPI-0209 in combination with Carboplatin chemotherapy followed by CPI-0209 maintenance in patients with platinum sensitive, recurrent ovarian cancer.
Phase 1 • Sponsor: Lan Coffman • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Which drug best steadies blood pressure during C-Section in preeclampsia?
Disease control Completedintermittent bolus doses of phenylephrine, norepinephrine and ephedrine for the management of spinal induced hypotension in preeclamptic patients
Sponsor: Minia University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for Tough-to-Treat colorectal cancer?
Disease control OngoingThis is an open-label clinical trial aimed at evaluating the safety and efficacy of the combination treatment of nelmastobart with capecitabine in patients diagnosed with metastatic or recurrent colorectal cancer.
Phase 1/2 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:25 UTC